 | • レポートコード：MRC2-11QY14530 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はPVAフォーム塞栓粒子のグローバル市場について調査・分析したレポートです。種類別（50μm〜350μm、350μm〜560μm、560μm〜710μm、710μm〜1000μm、1000μm〜1400μm、1400μm〜2000μm）市場規模、用途別（子宮線維塞栓術、前立腺動脈塞栓術（良性前立腺肥大症/BPH治療）、肝腫瘍塞栓術、外傷塞栓術、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別PVAフォーム塞栓粒子の競争状況、市場シェア ・世界のPVAフォーム塞栓粒子市場：種類別市場規模 2015年-2020年（50μm〜350μm、350μm〜560μm、560μm〜710μm、710μm〜1000μm、1000μm〜1400μm、1400μm〜2000μm） ・世界のPVAフォーム塞栓粒子市場：種類別市場規模予測 2021年-2026年（50μm〜350μm、350μm〜560μm、560μm〜710μm、710μm〜1000μm、1000μm〜1400μm、1400μm〜2000μm） ・世界のPVAフォーム塞栓粒子市場：用途別市場規模 2015年-2020年（子宮線維塞栓術、前立腺動脈塞栓術（良性前立腺肥大症/BPH治療）、肝腫瘍塞栓術、外傷塞栓術、その他） ・世界のPVAフォーム塞栓粒子市場：用途別市場規模予測 2021年-2026年（子宮線維塞栓術、前立腺動脈塞栓術（良性前立腺肥大症/BPH治療）、肝腫瘍塞栓術、外傷塞栓術、その他） ・北米のPVAフォーム塞栓粒子市場分析：米国、カナダ ・ヨーロッパのPVAフォーム塞栓粒子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのPVAフォーム塞栓粒子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のPVAフォーム塞栓粒子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのPVAフォーム塞栓粒子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Cook Medical、Sirtex Medical、Merit Medical、BTG Medical、Boston Scientific Corporation、Terumo Corporation、HENGRUI Medical、INterface BIOmaterials B.V.、Alicon ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global PVA Foam Embolization Particles Market
The global PVA Foam Embolization Particles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global PVA Foam Embolization Particles Scope and Market Size
PVA Foam Embolization Particles market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global PVA Foam Embolization Particles market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the PVA Foam Embolization Particles market is segmented into
50μm～350μm
350μm～560μm
560μm～710μm
710μm～1000μm
1000μm～1400μm
1400μm～2000μm
Segment by Application, the PVA Foam Embolization Particles market is segmented into
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Other
Regional and Country-level Analysis
The PVA Foam Embolization Particles market is analysed and market size information is provided by regions (countries).
The key regions covered in the PVA Foam Embolization Particles market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and PVA Foam Embolization Particles Market Share Analysis
PVA Foam Embolization Particles market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PVA Foam Embolization Particles business, the date to enter into the PVA Foam Embolization Particles market, PVA Foam Embolization Particles product introduction, recent developments, etc.
The major vendors covered:
Cook Medical
Sirtex Medical
Merit Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
1 Study Coverage
1.1 PVA Foam Embolization Particles Product Introduction
1.2 Market Segments
1.3 Key PVA Foam Embolization Particles Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global PVA Foam Embolization Particles Market Size Growth Rate by Type
1.4.2 50μm～350μm
1.4.3 350μm～560μm
1.4.4 560μm～710μm
1.4.5 710μm～1000μm
1.4.6 1000μm～1400μm
1.4.7 1400μm～2000μm
1.5 Market by Application
1.5.1 Global PVA Foam Embolization Particles Market Size Growth Rate by Application
1.5.2 Uterine Fibroid Embolization
1.5.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.5.4 Liver Tumor Embolization
1.5.5 Trauma Embolization
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global PVA Foam Embolization Particles Market Size, Estimates and Forecasts
2.1.1 Global PVA Foam Embolization Particles Revenue 2015-2026
2.1.2 Global PVA Foam Embolization Particles Sales 2015-2026
2.2 Global PVA Foam Embolization Particles, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global PVA Foam Embolization Particles Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global PVA Foam Embolization Particles Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global PVA Foam Embolization Particles Competitor Landscape by Players
3.1 PVA Foam Embolization Particles Sales by Manufacturers
3.1.1 PVA Foam Embolization Particles Sales by Manufacturers (2015-2020)
3.1.2 PVA Foam Embolization Particles Sales Market Share by Manufacturers (2015-2020)
3.2 PVA Foam Embolization Particles Revenue by Manufacturers
3.2.1 PVA Foam Embolization Particles Revenue by Manufacturers (2015-2020)
3.2.2 PVA Foam Embolization Particles Revenue Share by Manufacturers (2015-2020)
3.2.3 Global PVA Foam Embolization Particles Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by PVA Foam Embolization Particles Revenue in 2019
3.2.5 Global PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 PVA Foam Embolization Particles Price by Manufacturers
3.4 PVA Foam Embolization Particles Manufacturing Base Distribution, Product Types
3.4.1 PVA Foam Embolization Particles Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers PVA Foam Embolization Particles Product Type
3.4.3 Date of International Manufacturers Enter into PVA Foam Embolization Particles Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global PVA Foam Embolization Particles Market Size by Type (2015-2020)
4.1.1 Global PVA Foam Embolization Particles Sales by Type (2015-2020)
4.1.2 Global PVA Foam Embolization Particles Revenue by Type (2015-2020)
4.1.3 PVA Foam Embolization Particles Average Selling Price (ASP) by Type (2015-2026)
4.2 Global PVA Foam Embolization Particles Market Size Forecast by Type (2021-2026)
4.2.1 Global PVA Foam Embolization Particles Sales Forecast by Type (2021-2026)
4.2.2 Global PVA Foam Embolization Particles Revenue Forecast by Type (2021-2026)
4.2.3 PVA Foam Embolization Particles Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global PVA Foam Embolization Particles Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global PVA Foam Embolization Particles Market Size by Application (2015-2020)
5.1.1 Global PVA Foam Embolization Particles Sales by Application (2015-2020)
5.1.2 Global PVA Foam Embolization Particles Revenue by Application (2015-2020)
5.1.3 PVA Foam Embolization Particles Price by Application (2015-2020)
5.2 PVA Foam Embolization Particles Market Size Forecast by Application (2021-2026)
5.2.1 Global PVA Foam Embolization Particles Sales Forecast by Application (2021-2026)
5.2.2 Global PVA Foam Embolization Particles Revenue Forecast by Application (2021-2026)
5.2.3 Global PVA Foam Embolization Particles Price Forecast by Application (2021-2026)
6 North America
6.1 North America PVA Foam Embolization Particles by Country
6.1.1 North America PVA Foam Embolization Particles Sales by Country
6.1.2 North America PVA Foam Embolization Particles Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America PVA Foam Embolization Particles Market Facts & Figures by Type
6.3 North America PVA Foam Embolization Particles Market Facts & Figures by Application
7 Europe
7.1 Europe PVA Foam Embolization Particles by Country
7.1.1 Europe PVA Foam Embolization Particles Sales by Country
7.1.2 Europe PVA Foam Embolization Particles Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe PVA Foam Embolization Particles Market Facts & Figures by Type
7.3 Europe PVA Foam Embolization Particles Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific PVA Foam Embolization Particles by Region
8.1.1 Asia Pacific PVA Foam Embolization Particles Sales by Region
8.1.2 Asia Pacific PVA Foam Embolization Particles Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific PVA Foam Embolization Particles Market Facts & Figures by Type
8.3 Asia Pacific PVA Foam Embolization Particles Market Facts & Figures by Application
9 Latin America
9.1 Latin America PVA Foam Embolization Particles by Country
9.1.1 Latin America PVA Foam Embolization Particles Sales by Country
9.1.2 Latin America PVA Foam Embolization Particles Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America PVA Foam Embolization Particles Market Facts & Figures by Type
9.3 Central & South America PVA Foam Embolization Particles Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa PVA Foam Embolization Particles by Country
10.1.1 Middle East and Africa PVA Foam Embolization Particles Sales by Country
10.1.2 Middle East and Africa PVA Foam Embolization Particles Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa PVA Foam Embolization Particles Market Facts & Figures by Type
10.3 Middle East and Africa PVA Foam Embolization Particles Market Facts & Figures by Application
11 Company Profiles
11.1 Cook Medical
11.1.1 Cook Medical Corporation Information
11.1.2 Cook Medical Description and Business Overview
11.1.3 Cook Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cook Medical PVA Foam Embolization Particles Products Offered
11.1.5 Cook Medical Related Developments
11.2 Sirtex Medical
11.2.1 Sirtex Medical Corporation Information
11.2.2 Sirtex Medical Description and Business Overview
11.2.3 Sirtex Medical Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sirtex Medical PVA Foam Embolization Particles Products Offered
11.2.5 Sirtex Medical Related Developments
11.3 Merit Medical
11.3.1 Merit Medical Corporation Information
11.3.2 Merit Medical Description and Business Overview
11.3.3 Merit Medical Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merit Medical PVA Foam Embolization Particles Products Offered
11.3.5 Merit Medical Related Developments
11.4 BTG Medical
11.4.1 BTG Medical Corporation Information
11.4.2 BTG Medical Description and Business Overview
11.4.3 BTG Medical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BTG Medical PVA Foam Embolization Particles Products Offered
11.4.5 BTG Medical Related Developments
11.5 Boston Scientific Corporation
11.5.1 Boston Scientific Corporation Corporation Information
11.5.2 Boston Scientific Corporation Description and Business Overview
11.5.3 Boston Scientific Corporation Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Boston Scientific Corporation PVA Foam Embolization Particles Products Offered
11.5.5 Boston Scientific Corporation Related Developments
11.6 Terumo Corporation
11.6.1 Terumo Corporation Corporation Information
11.6.2 Terumo Corporation Description and Business Overview
11.6.3 Terumo Corporation Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Terumo Corporation PVA Foam Embolization Particles Products Offered
11.6.5 Terumo Corporation Related Developments
11.7 HENGRUI Medical
11.7.1 HENGRUI Medical Corporation Information
11.7.2 HENGRUI Medical Description and Business Overview
11.7.3 HENGRUI Medical Sales, Revenue and Gross Margin (2015-2020)
11.7.4 HENGRUI Medical PVA Foam Embolization Particles Products Offered
11.7.5 HENGRUI Medical Related Developments
11.8 INterface BIOmaterials B.V.
11.8.1 INterface BIOmaterials B.V. Corporation Information
11.8.2 INterface BIOmaterials B.V. Description and Business Overview
11.8.3 INterface BIOmaterials B.V. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 INterface BIOmaterials B.V. PVA Foam Embolization Particles Products Offered
11.8.5 INterface BIOmaterials B.V. Related Developments
11.9 Alicon
11.9.1 Alicon Corporation Information
11.9.2 Alicon Description and Business Overview
11.9.3 Alicon Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Alicon PVA Foam Embolization Particles Products Offered
11.9.5 Alicon Related Developments
11.1 Cook Medical
11.1.1 Cook Medical Corporation Information
11.1.2 Cook Medical Description and Business Overview
11.1.3 Cook Medical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cook Medical PVA Foam Embolization Particles Products Offered
11.1.5 Cook Medical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 PVA Foam Embolization Particles Market Estimates and Projections by Region
12.1.1 Global PVA Foam Embolization Particles Sales Forecast by Regions 2021-2026
12.1.2 Global PVA Foam Embolization Particles Revenue Forecast by Regions 2021-2026
12.2 North America PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.2.1 North America: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.2.2 North America: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.2.3 North America: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
12.3 Europe PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.3.1 Europe: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.3.2 Europe: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.3.3 Europe: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.4.2 Asia Pacific: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: PVA Foam Embolization Particles Market Size Forecast by Region (2021-2026)
12.5 Latin America PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.5.1 Latin America: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.5.2 Latin America: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.5.3 Latin America: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa PVA Foam Embolization Particles Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: PVA Foam Embolization Particles Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: PVA Foam Embolization Particles Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: PVA Foam Embolization Particles Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key PVA Foam Embolization Particles Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 PVA Foam Embolization Particles Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. PVA Foam Embolization Particles Market Segments
Table 2. Ranking of Global Top PVA Foam Embolization Particles Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global PVA Foam Embolization Particles Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 50μm～350μm
Table 5. Major Manufacturers of 350μm～560μm
Table 6. Major Manufacturers of 560μm～710μm
Table 7. Major Manufacturers of 710μm～1000μm
Table 8. Major Manufacturers of 1000μm～1400μm
Table 9. Major Manufacturers of 1400μm～2000μm
Table 10. Global PVA Foam Embolization Particles Market Size Growth Rate by Application 2020-2026 (K Units)
Table 11. Global PVA Foam Embolization Particles Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 12. Global PVA Foam Embolization Particles Sales by Regions 2015-2020 (K Units)
Table 13. Global PVA Foam Embolization Particles Sales Market Share by Regions (2015-2020)
Table 14. Global PVA Foam Embolization Particles Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global PVA Foam Embolization Particles Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global PVA Foam Embolization Particles Sales Share by Manufacturers (2015-2020)
Table 17. Global PVA Foam Embolization Particles Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global PVA Foam Embolization Particles by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PVA Foam Embolization Particles as of 2019)
Table 19. PVA Foam Embolization Particles Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. PVA Foam Embolization Particles Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers PVA Foam Embolization Particles Price (2015-2020) (USD/Unit)
Table 22. PVA Foam Embolization Particles Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers PVA Foam Embolization Particles Product Type
Table 24. Date of International Manufacturers Enter into PVA Foam Embolization Particles Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 27. Global PVA Foam Embolization Particles Sales Share by Type (2015-2020)
Table 28. Global PVA Foam Embolization Particles Revenue by Type (2015-2020) (US$ Million)
Table 29. Global PVA Foam Embolization Particles Revenue Share by Type (2015-2020)
Table 30. PVA Foam Embolization Particles Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 32. Global PVA Foam Embolization Particles Sales Share by Application (2015-2020)
Table 33. North America PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 34. North America PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 35. North America PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 36. North America PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 37. North America PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 38. North America PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 39. North America PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 40. North America PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 41. Europe PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 42. Europe PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 43. Europe PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 45. Europe PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 46. Europe PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 47. Europe PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 48. Europe PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific PVA Foam Embolization Particles Sales by Region (2015-2020) (K Units)
Table 50. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific PVA Foam Embolization Particles Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific PVA Foam Embolization Particles Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 54. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 56. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 57. Latin America PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 58. Latin America PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 61. Latin America PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 62. Latin America PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 63. Latin America PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 64. Latin America PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa PVA Foam Embolization Particles Sales by Country (2015-2020) (K Units)
Table 66. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa PVA Foam Embolization Particles Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa PVA Foam Embolization Particles Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa PVA Foam Embolization Particles Sales by Type (2015-2020) (K Units)
Table 70. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa PVA Foam Embolization Particles Sales by Application (2015-2020) (K Units)
Table 72. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Table 73. Cook Medical Corporation Information
Table 74. Cook Medical Description and Major Businesses
Table 75. Cook Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Cook Medical Product
Table 77. Cook Medical Recent Development
Table 78. Sirtex Medical Corporation Information
Table 79. Sirtex Medical Description and Major Businesses
Table 80. Sirtex Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Sirtex Medical Product
Table 82. Sirtex Medical Recent Development
Table 83. Merit Medical Corporation Information
Table 84. Merit Medical Description and Major Businesses
Table 85. Merit Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Merit Medical Product
Table 87. Merit Medical Recent Development
Table 88. BTG Medical Corporation Information
Table 89. BTG Medical Description and Major Businesses
Table 90. BTG Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. BTG Medical Product
Table 92. BTG Medical Recent Development
Table 93. Boston Scientific Corporation Corporation Information
Table 94. Boston Scientific Corporation Description and Major Businesses
Table 95. Boston Scientific Corporation PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Boston Scientific Corporation Product
Table 97. Boston Scientific Corporation Recent Development
Table 98. Terumo Corporation Corporation Information
Table 99. Terumo Corporation Description and Major Businesses
Table 100. Terumo Corporation PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Terumo Corporation Product
Table 102. Terumo Corporation Recent Development
Table 103. HENGRUI Medical Corporation Information
Table 104. HENGRUI Medical Description and Major Businesses
Table 105. HENGRUI Medical PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. HENGRUI Medical Product
Table 107. HENGRUI Medical Recent Development
Table 108. INterface BIOmaterials B.V. Corporation Information
Table 109. INterface BIOmaterials B.V. Description and Major Businesses
Table 110. INterface BIOmaterials B.V. PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. INterface BIOmaterials B.V. Product
Table 112. INterface BIOmaterials B.V. Recent Development
Table 113. Alicon Corporation Information
Table 114. Alicon Description and Major Businesses
Table 115. Alicon PVA Foam Embolization Particles Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Alicon Product
Table 117. Alicon Recent Development
Table 118. Global PVA Foam Embolization Particles Sales Forecast by Regions (2021-2026) (K Units)
Table 119. Global PVA Foam Embolization Particles Sales Market Share Forecast by Regions (2021-2026)
Table 120. Global PVA Foam Embolization Particles Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 121. Global PVA Foam Embolization Particles Revenue Market Share Forecast by Regions (2021-2026)
Table 122. North America: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 123. North America: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Europe: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 125. Europe: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Asia Pacific: PVA Foam Embolization Particles Sales Forecast by Region (2021-2026) (K Units)
Table 127. Asia Pacific: PVA Foam Embolization Particles Revenue Forecast by Region (2021-2026) (US$ Million)
Table 128. Latin America: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 129. Latin America: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Middle East and Africa: PVA Foam Embolization Particles Sales Forecast by Country (2021-2026) (K Units)
Table 131. Middle East and Africa: PVA Foam Embolization Particles Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 133. Key Challenges
Table 134. Market Risks
Table 135. Main Points Interviewed from Key PVA Foam Embolization Particles Players
Table 136. PVA Foam Embolization Particles Customers List
Table 137. PVA Foam Embolization Particles Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. PVA Foam Embolization Particles Product Picture
Figure 2. Global PVA Foam Embolization Particles Sales Market Share by Type in 2020 & 2026
Figure 3. 50μm～350μm Product Picture
Figure 4. 350μm～560μm Product Picture
Figure 5. 560μm～710μm Product Picture
Figure 6. 710μm～1000μm Product Picture
Figure 7. 1000μm～1400μm Product Picture
Figure 8. 1400μm～2000μm Product Picture
Figure 9. Global PVA Foam Embolization Particles Sales Market Share by Application in 2020 & 2026
Figure 10. Uterine Fibroid Embolization
Figure 11. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Figure 12. Liver Tumor Embolization
Figure 13. Trauma Embolization
Figure 14. Other
Figure 15. PVA Foam Embolization Particles Report Years Considered
Figure 16. Global PVA Foam Embolization Particles Market Size 2015-2026 (US$ Million)
Figure 17. Global PVA Foam Embolization Particles Sales 2015-2026 (K Units)
Figure 18. Global PVA Foam Embolization Particles Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global PVA Foam Embolization Particles Sales Market Share by Region (2015-2020)
Figure 20. Global PVA Foam Embolization Particles Sales Market Share by Region in 2019
Figure 21. Global PVA Foam Embolization Particles Revenue Market Share by Region (2015-2020)
Figure 22. Global PVA Foam Embolization Particles Revenue Market Share by Region in 2019
Figure 23. Global PVA Foam Embolization Particles Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by PVA Foam Embolization Particles Revenue in 2019
Figure 25. PVA Foam Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global PVA Foam Embolization Particles Sales Market Share by Type (2015-2020)
Figure 27. Global PVA Foam Embolization Particles Sales Market Share by Type in 2019
Figure 28. Global PVA Foam Embolization Particles Revenue Market Share by Type (2015-2020)
Figure 29. Global PVA Foam Embolization Particles Revenue Market Share by Type in 2019
Figure 30. Global PVA Foam Embolization Particles Market Share by Price Range (2015-2020)
Figure 31. Global PVA Foam Embolization Particles Sales Market Share by Application (2015-2020)
Figure 32. Global PVA Foam Embolization Particles Sales Market Share by Application in 2019
Figure 33. Global PVA Foam Embolization Particles Revenue Market Share by Application (2015-2020)
Figure 34. Global PVA Foam Embolization Particles Revenue Market Share by Application in 2019
Figure 35. North America PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 36. North America PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America PVA Foam Embolization Particles Sales Market Share by Country in 2019
Figure 38. North America PVA Foam Embolization Particles Revenue Market Share by Country in 2019
Figure 39. U.S. PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 40. U.S. PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 42. Canada PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America PVA Foam Embolization Particles Market Share by Type in 2019
Figure 44. North America PVA Foam Embolization Particles Market Share by Application in 2019
Figure 45. Europe PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 46. Europe PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe PVA Foam Embolization Particles Sales Market Share by Country in 2019
Figure 48. Europe PVA Foam Embolization Particles Revenue Market Share by Country in 2019
Figure 49. Germany PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 50. Germany PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 52. France PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 54. U.K. PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 56. Italy PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 58. Russia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe PVA Foam Embolization Particles Market Share by Type in 2019
Figure 60. Europe PVA Foam Embolization Particles Market Share by Application in 2019
Figure 61. Asia Pacific PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 62. Asia Pacific PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific PVA Foam Embolization Particles Sales Market Share by Region in 2019
Figure 64. Asia Pacific PVA Foam Embolization Particles Revenue Market Share by Region in 2019
Figure 65. China PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 66. China PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 68. Japan PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 70. South Korea PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 72. India PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 74. Australia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 76. Taiwan PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 78. Indonesia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 80. Thailand PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 82. Malaysia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 84. Philippines PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 86. Vietnam PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific PVA Foam Embolization Particles Market Share by Type in 2019
Figure 88. Asia Pacific PVA Foam Embolization Particles Market Share by Application in 2019
Figure 89. Latin America PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America PVA Foam Embolization Particles Sales Market Share by Country in 2019
Figure 92. Latin America PVA Foam Embolization Particles Revenue Market Share by Country in 2019
Figure 93. Mexico PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 98. Argentina PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America PVA Foam Embolization Particles Market Share by Type in 2019
Figure 100. Latin America PVA Foam Embolization Particles Market Share by Application in 2019
Figure 101. Middle East and Africa PVA Foam Embolization Particles Sales Growth Rate 2015-2020 (K Units)
Figure 102. Middle East and Africa PVA Foam Embolization Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa PVA Foam Embolization Particles Sales Market Share by Country in 2019
Figure 104. Middle East and Africa PVA Foam Embolization Particles Revenue Market Share by Country in 2019
Figure 105. Turkey PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 106. Turkey PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 108. Saudi Arabia PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E PVA Foam Embolization Particles Sales Growth Rate (2015-2020) (K Units)
Figure 110. U.A.E PVA Foam Embolization Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa PVA Foam Embolization Particles Market Share by Type in 2019
Figure 112. Middle East and Africa PVA Foam Embolization Particles Market Share by Application in 2019
Figure 113. North America PVA Foam Embolization Particles Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. North America PVA Foam Embolization Particles Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe PVA Foam Embolization Particles Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Europe PVA Foam Embolization Particles Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific PVA Foam Embolization Particles Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Asia Pacific PVA Foam Embolization Particles Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America PVA Foam Embolization Particles Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 120. Latin America PVA Foam Embolization Particles Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa PVA Foam Embolization Particles Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 122. Middle East and Africa PVA Foam Embolization Particles Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
子宮筋腫塞栓術の世界市場（～2026年） Uterine fibroid embolization (UFE) is an effective, non-surgical method used to treat uterine fibroids in the fertile women population. It is performed with the help of uterine fibroid embolization agents, delivered to the tumor by micro-catheters. The embolization agents block the arteries supplyin…- 硬質PUフォームの世界市場（～2026年） Rigid PU foam is one of the most efficient, high performance insulation materials, enabling very effective energy savings with minimal occupation of space. Market Analysis and Insights: Global Rigid PU Foam Market The global Rigid PU Foam market size is projected to reach US$ XX million by 2026, fro…
- 堆肥化可能粒子フォームの世界市場（～2026年） The compostable or biodegradable terms have become an essential part of day to day life. The growing consumer awareness and preference towards eco-friendly options is resulting into paradigm shift for the use of green products. Introduction of compostable particle foam is one of the prominent step t…
- パッキングピーナッツの世界市場（～2026年） Foam peanuts, also known as packing peanuts or packing noodles, are a common loose-fill packaging and cushioning material used to prevent damage to fragile objects during shipping. They are shaped to interlock when compressed and free flow when not compressed. Market Analysis and Insights: Global Fo…
- PUフォームスタビライザーの世界市場（～2026年） PU Foam Stabilizer is used for foam preparation. Market Analysis and Insights: Global PU Foam Stabilizer Market The global PU Foam Stabilizer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global PU Foam Stabilizer Scope and…